tiprankstipranks
Alembic Pharmaceuticals Limited (IN:APLLTD)
:APLLTD
India Market
APLLTD
Alembic Pharmaceuticals Limited
RESEARCH TOOLSreports
Want to see IN:APLLTD full AI Analyst Report?

Alembic Pharmaceuticals Limited (APLLTD) Ratios

2 Followers

Alembic Pharmaceuticals Limited Ratios

IN:APLLTD's free cash flow for Q2 2026 was ₹0.46. For the 2026 fiscal year, IN:APLLTD's free cash flow was decreased by ₹ and operating cash flow was ₹0.13. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.76 1.76 1.69 2.12 1.78
Quick Ratio
 0.79 0.79 0.75 0.99 0.88
Cash Ratio
 0.08 0.08 0.04 0.08 0.05
Solvency Ratio
 0.32 0.32 0.33 0.53 0.33
Operating Cash Flow Ratio
 0.16 0.27 0.04 0.55 0.44
Short-Term Operating Cash Flow Coverage
 0.32 0.55 0.07 1.87 1.14
Net Current Asset Value
₹ 14.79B₹ 14.79B₹ 15.04B₹ 14.51B₹ 10.98B
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.16 0.16 0.08 0.12
Debt-to-Equity Ratio
 0.25 0.25 0.24 0.11 0.17
Debt-to-Capital Ratio
 0.20 0.20 0.20 0.10 0.14
Long-Term Debt-to-Capital Ratio
 0.02 0.02 0.00 0.00 0.00
Financial Leverage Ratio
 1.54 1.54 1.50 1.34 1.41
Debt Service Coverage Ratio
 0.79 0.81 0.68 1.85 1.00
Interest Coverage Ratio
 15.73 8.54 34.30 44.64 39.48
Debt to Market Cap
 0.09 0.11 0.07 0.02 0.07
Interest Debt Per Share
 77.49 77.51 67.98 28.97 39.28
Net Debt to EBITDA
 1.13 1.10 1.18 0.43 0.93
Profitability Margins
Gross Profit Margin
51.83%45.06%71.81%71.16%68.60%
EBIT Margin
10.62%10.89%10.94%10.61%7.74%
EBITDA Margin
14.84%15.23%14.82%14.68%12.32%
Operating Profit Margin
20.05%10.89%40.49%40.27%35.04%
Pretax Profit Margin
9.45%9.45%10.60%10.14%6.27%
Net Profit Margin
9.19%9.19%8.74%9.89%6.05%
Continuous Operations Profit Margin
9.13%9.13%8.72%9.89%6.05%
Net Income Per EBT
97.23%97.24%82.50%97.47%96.44%
EBT Per EBIT
47.12%86.75%26.17%25.19%17.90%
Return on Assets (ROA)
7.70%7.70%7.51%9.55%5.53%
Return on Equity (ROE)
12.63%11.89%11.24%12.78%7.83%
Return on Capital Employed (ROCE)
23.88%12.97%50.40%50.26%43.57%
Return on Invested Capital (ROIC)
19.16%10.40%33.84%44.94%36.74%
Return on Tangible Assets
7.96%7.96%7.51%9.55%5.53%
Earnings Yield
4.58%5.18%3.31%3.11%3.51%
Efficiency Ratios
Receivables Turnover
 5.01 5.01 4.77 6.08 5.38
Payables Turnover
 4.24 4.83 2.14 2.44 2.61
Inventory Turnover
 1.41 1.61 0.82 1.09 1.20
Fixed Asset Turnover
 2.11 2.11 1.99 2.03 1.88
Asset Turnover
 0.84 0.84 0.86 0.97 0.91
Working Capital Turnover Ratio
 4.08 4.02 4.04 4.30 4.68
Cash Conversion Cycle
 245.71 224.44 349.88 244.56 231.48
Days of Sales Outstanding
 72.87 72.87 76.58 60.06 67.89
Days of Inventory Outstanding
 258.98 227.11 444.06 333.99 303.40
Days of Payables Outstanding
 86.14 75.54 170.76 149.49 139.81
Operating Cycle
 331.85 299.98 520.64 394.05 371.29
Cash Flow Ratios
Operating Cash Flow Per Share
 20.49 35.38 4.48 40.86 36.83
Free Cash Flow Per Share
 8.58 13.26 -24.20 24.20 14.27
CapEx Per Share
 11.91 22.11 28.67 16.66 22.56
Free Cash Flow to Operating Cash Flow
 0.42 0.37 -5.41 0.59 0.39
Dividend Paid and CapEx Coverage Ratio
 0.89 1.07 0.11 1.66 1.13
Capital Expenditure Coverage Ratio
 1.72 1.60 0.16 2.45 1.63
Operating Cash Flow Coverage Ratio
 0.28 0.49 0.07 1.57 1.00
Operating Cash Flow to Sales Ratio
 0.05 0.09 0.01 0.13 0.13
Free Cash Flow Yield
1.15%2.00%-2.70%2.40%2.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 21.82 19.32 30.22 32.20 28.53
Price-to-Sales (P/S) Ratio
 2.00 1.77 2.64 3.18 1.73
Price-to-Book (P/B) Ratio
 2.59 2.30 3.40 4.12 2.23
Price-to-Free Cash Flow (P/FCF) Ratio
 87.23 50.01 -37.06 41.69 34.78
Price-to-Operating Cash Flow Ratio
 36.54 18.75 200.40 24.69 13.48
Price-to-Earnings Growth (PEG) Ratio
 1.38 1.23 -5.74 0.40 -0.83
Price-to-Fair Value
 2.59 2.30 3.40 4.12 2.23
Enterprise Value Multiple
 14.64 12.75 19.00 22.13 14.94
Enterprise Value
 159.48B 142.64B 187.96B 202.25B 104.03B
EV to EBITDA
 14.64 12.75 19.00 22.13 14.94
EV to Sales
 2.17 1.94 2.82 3.25 1.84
EV to Free Cash Flow
 94.51 54.72 -39.52 42.51 37.08
EV to Operating Cash Flow
 39.58 20.51 213.67 25.18 14.37
Tangible Book Value Per Share
 288.34 288.42 264.01 245.12 222.34
Shareholders’ Equity Per Share
 288.64 288.72 264.09 245.12 222.34
Tax and Other Ratios
Effective Tax Rate
 0.03 0.03 0.18 0.03 0.04
Revenue Per Share
 373.59 373.68 339.44 316.88 287.57
Net Income Per Share
 34.32 34.33 29.68 31.33 17.40
Tax Burden
 0.97 0.97 0.82 0.97 0.96
Interest Burden
 0.89 0.87 0.97 0.96 0.81
Research & Development to Revenue
 0.00 0.00 0.08 0.08 0.13
SG&A to Revenue
 0.32 0.34 0.23 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.51 1.03 0.15 1.30 2.04
Currency in INR